- PRINCIPAL DISPLAY PANEL - 20 mg Blister Pack Carton
- PRINCIPAL DISPLAY PANEL - 20 mg Blister Pack
-
INGREDIENTS AND APPEARANCE
VYNDAQEL
tafamidis meglumine capsuleProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0069-8729 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength TAFAMIDIS MEGLUMINE (UNII: ZU7CF08A1A) (TAFAMIDIS - UNII:8FG9H9D31J) TAFAMIDIS MEGLUMINE 20 mg Inactive Ingredients Ingredient Name Strength GELATIN (UNII: 2G86QN327L) GLYCERIN (UNII: PDC6A3C0OX) SORBITOL (UNII: 506T60A25R) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) WATER (UNII: 059QF0KO0R) MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U) POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ) SORBITAN MONOOLEATE (UNII: 06XEA2VD56) POLYSORBATE 80 (UNII: 6OZP39ZG8H) Product Characteristics Color WHITE Score no score Shape CAPSULE Size 10mm Flavor Imprint Code VYN20 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:0069-8729-55 1 in 1 CARTON 12/15/2015 1 30 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date EXPORT ONLY 12/15/2015 Labeler - Pfizer Labs Division of Pfizer Inc. (134489525) Establishment Name Address ID/FEI Business Operations DELMAR CHEMICALS INC 245906755 API MANUFACTURE(0069-8729) Establishment Name Address ID/FEI Business Operations Catalent Pharma Solutions, LLC 051762268 ANALYSIS(0069-8729) , MANUFACTURE(0069-8729) Establishment Name Address ID/FEI Business Operations AndersonBrecon Inc. 053217022 LABEL(0069-8729) , PACK(0069-8729) Establishment Name Address ID/FEI Business Operations Catalent Micron Technologies, Inc. 015966157 PARTICLE SIZE REDUCTION(0069-8729)